Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Govind Ballabh Pant Hospital
Age
12–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Clinical diagnosis of portal hypertension
Having hematemesis and/or melena within 24 hour prior to admission
Source of bleeding should be esophageal varices
You may not be if
Non-cirrhotic cause of portal hypertension
Age \<12 or \>75 years
Hepatic encephalopathy grade 3 or 4
Renal failure with serum creatinine \>2 mg/dL
Any evidence of bleeding from additional source apart from esophageal varices (like gastric varices, portal hypertensive gastropathy, erosions or ulcers including variceal ulcers)
Patients already on vasoactive drugs like somatostatin or terlipressin during the current episode of bleeding
Patients already received EVL or EST elsewhere during the current episode of bleeding prior to presenting to our hospital
Patients with history of surgery for portal hypertension or TIPS
Concomitant severe cardio-pulmonary disease
Concomitant malignancy
HVPG not possible within 24 hrs of presentation
Patients refusing to participate in the study.
Clareo Health | A Trial of Somatostatin With Endoscopic Variceal Ligation (EVL) in Control of Acute Variceal Bleeding
